161
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Prevalence of Congenital Hemolytic Disorders in Denmark, 2000–2016

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 485-495 | Published online: 21 May 2020

References

  • Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.11545326
  • Aguilar Martinez P, Angastiniotis M, Eleftheriou A, et al. Haemoglobinopathies in Europe: health & migration policy perspectives. Orphanet J Rare Dis. 2014;9(1):97. doi:10.1186/1750-1172-9-9724980780
  • Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;2008(6):480–487. doi:10.2471/BLT.06.036673
  • Taher AT, Weatherall DJ, Cappellini MD. Thalassaemia. Lancet (London, England). 2018;391(10116):155–167. doi:10.1016/S0140-6736(17)31822-6
  • Piel FB, Steinberg MH, Rees DC, Longo DL. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. doi:10.1056/NEJMra151086528423290
  • Kato GJ, Piel FB, Reid CD, et al. Sickle cell disease. Nat Rev Dis Primers. 2018;4:18010.29542687
  • Vichinsky EP. Changing patterns of thalassemia worldwide. Ann N Y Acad Sci. 2005;1054(1):18–24. doi:10.1196/annals.1345.00316339647
  • Modell B, Darlison M, Birgens H, et al. Epidemiology of haemoglobin disorders in Europe: an overview. Scand J Clin Lab Invest. 2007;67(1):39–69. doi:10.1080/0036551060104655717365984
  • Gulbis B, Eleftheriou A, Angastiniotis M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375–396.20824457
  • Weil LG, Charlton MR, Coppinger C, Daniel Y, Streetly A. Sickle cell disease and thalassaemia antenatal screening programme in England over 10 years: a review from 2007/2008 to 2016/2017. J Clin Pathol. 2019;73(4):183–90.31771971
  • Ballardini E, Tarocco A, Marsella M, et al. Universal neonatal screening for sickle cell disease and other haemoglobinopathies in Ferrara, Italy. Blood Transfus. 2013;11(2):245–249. doi:10.2450/2012.0030-1223058858
  • Perrotta S, Gallagher PG, Mohandas N. Hereditary spherocytosis. Lancet (London, England). 2008;372(9647):1411–1426. doi:10.1016/S0140-6736(08)61588-3
  • Eber SW, Pekrun A, Neufeldt A, Schroter W. Prevalence of increased osmotic fragility of erythrocytes in German blood donors: screening using a modified glycerol lysis test. Ann Hematol. 1992;64(2):88–92. doi:10.1007/BF017153511554800
  • Godal HC, Heisto H. High prevalence of increased osmotic fragility of red blood cells among Norwegian blood donors. Scand J Haematol. 1981;27(1):30–34. doi:10.1111/j.1600-0609.1981.tb00448.x7336156
  • Iolascon A, Andolfo I, Russo R. Advances in understanding the pathogenesis of red cell membrane disorders. Br J Haematol. 2019;187(1):13–24. doi:10.1111/bjh.1612631364155
  • Schmidt M, Schmidt SAJ, Adelborg K, et al. The Danish health care system and epidemiological research: from health care contacts to database records. Clin Epidemiol. 2019;11:563–591. doi:10.2147/CLEP.S17908331372058
  • Denmark S Statbank. https://www.statbank.dk/. Published 2018 Accessed 519, 2019..
  • Schmidt M, Pedersen L, Sorensen HT. The Danish Civil Registration System as a tool in epidemiology. Eur J Epidemiol. 2014;29(8):541–549. doi:10.1007/s10654-014-9930-324965263
  • Schmidt M, Schmidt SA, Sandegaard JL, Ehrenstein V, Pedersen L, Sorensen HT. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490. doi:10.2147/CLEP.S9112526604824
  • Hansen DL, Overgaard UM, Pedersen L, Frederiksen H. Positive predictive value of diagnosis coding for hemolytic anemias in the Danish National Patient Register. Clin Epidemiol. 2016;8:241–252. doi:10.2147/CLEP.S9364327445504
  • Benchimol EI, Smeeth L, Guttmann A, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885. doi:10.1371/journal.pmed.100188526440803
  • StataCorp LP. Stata Statistical Software: Release 15 [Computer Program]. College Station, TX: StataCorp LLC; 2017.
  • Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika. 1934;26(4):404–413. doi:10.1093/biomet/26.4.404
  • StataCorp. Stata base referecen manual release. 15 Stata Press; 2017.
  • Skov T, Deddens J, Petersen MR, Endahl L. Prevalence proportion ratios: estimation and hypothesis testing. Int J Epidemiol. 1998;27(1):91–95. doi:10.1093/ije/27.1.919563700
  • Luzzatto L, Arese P, Longo DL. Favism and glucose-6-phosphate dehydrogenase deficiency. N Engl J Med. 2018;378(1):60–71. doi:10.1056/NEJMra170811129298156
  • Luzzatto L, Nannelli C, Notaro R. Glucose-6-phosphate dehydrogenase deficiency. Hematol Oncol Clin North Am. 2016;30(2):373–393. doi:10.1016/j.hoc.2015.11.00627040960
  • Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7(5):450–453. doi:10.1016/j.jcf.2008.03.00718442953
  • Ciepiela O. Old and new insights into the diagnosis of hereditary spherocytosis. Ann Transl Med. 2018;6(17):339. doi:10.21037/atm.2018.07.3530306078
  • Delhommeau F, Cynober T, Schischmanoff PO, et al. Natural history of hereditary spherocytosis during the first year of life. Blood. 2000;95(2):393–397. doi:10.1182/blood.V95.2.39310627440
  • Eber S, Lux SE. Hereditary spherocytosis–defects in proteins that connect the membrane skeleton to the lipid bilayer. Semin Hematol. 2004;41(2):118–141. doi:10.1053/j.seminhematol.2004.01.00215071790
  • 1Sickle cell anaemia. Agenda item 11.4. 59th World Health Assembly Vol. WHA59/2006/REC/1 World Health Organization; 2006.
  • Thalassaemia and other haemoglobinopathies. Agenda item 5.2. 59th World Health Assembly 2006: EB118.R1